Microsoft Expands Life Sciences Effort - InformationWeek

InformationWeek is part of the Informa Tech Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them.Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

IoT
IoT
Software // Enterprise Applications
News
10/19/2006
05:35 PM
50%
50%

Microsoft Expands Life Sciences Effort

Microsoft cut deals with several life sciences and software companies for software that helps researchers visualize molecules and run tests of the efficacy of potential drug compounds.

Microsoft said Thursday it has struck agreements with several life sciences and software companies to develop and distribute software to help researchers create new drugs.

Microsoft said it reached a deal with IO Informatics, a maker of software for pharmaceutical and biotechnology companies, to commercialize prototype software for visualizing molecules and appending notes and data to the images. The software, called "Collaborative Molecular Environment," was written by InterKnowlogy, a contract software developer that builds products and prototypes for Microsoft. The app lets scientists annotate molecular images with notes, spreadsheets, or links to published research. Scientists can access the system over the Web and search their annotations for key phrases.

The software takes advantage of graphics technology in Windows Vista and the SharePoint Server collaboration software.

Microsoft also launched a project with Agilent Technologies, Applied Biosystems, and Illumina, which make laboratory equipment for analysis of DNA, to integrate data that's output from the machinery with clinical trial data on the efficacy of potential drug compounds. Microsoft plans to let its Excel spreadsheet and business intelligence software import the married data using Web services.

Microsoft hopes the work will act as a catalyst for other software development, eventually helping biotechnology researchers more quickly validate hypotheses, says Don Rule, a platform strategy advisor in Microsoft's developer evangelist group. "We're not a science company," he says. "We want to specify the interfaces" between sample and clinical data, in many cases writing Web services that incorporate already defined standards.

We welcome your comments on this topic on our social media channels, or [contact us directly] with questions about the site.
Comment  | 
Print  | 
More Insights
InformationWeek Is Getting an Upgrade!

Find out more about our plans to improve the look, functionality, and performance of the InformationWeek site in the coming months.

News
Pandemic Responses Make Room for More Data Opportunities
Jessica Davis, Senior Editor, Enterprise Apps,  5/4/2021
Slideshows
10 Things Your Artificial Intelligence Initiative Needs to Succeed
Lisa Morgan, Freelance Writer,  4/20/2021
News
Transformation, Disruption, and Gender Diversity in Tech
Joao-Pierre S. Ruth, Senior Writer,  5/6/2021
White Papers
Register for InformationWeek Newsletters
Video
Current Issue
Planning Your Digital Transformation Roadmap
Download this report to learn about the latest technologies and best practices or ensuring a successful transition from outdated business transformation tactics.
Slideshows
Flash Poll